| 发明名称 |
HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDE |
| 摘要 |
<p>HLA-A24-restricted peptides derived from WT1 which have an activity to induce CTLs in vivo, polynucleotides encoding said peptides, cancer vaccines using those peptides or polynucleotides in vivo or in vitro, or the like are provided. The cancer vaccines of the present invention may be used to treat many cancer patients.</p> |
| 申请公布号 |
EP1536009(A1) |
申请公布日期 |
2005.06.01 |
| 申请号 |
EP20030736167 |
申请日期 |
2003.06.12 |
| 申请人 |
SUGIYAMA, HARUO;CHUGAI SEIYAKU KABUSHIKI KAISHA;SUMITOMO PHARMACEUTICALS COMPANY, LIMITED |
发明人 |
SUGIYAMA, HARUO;GOTOH, MASASHI;TAKASU, HIDEO |
| 分类号 |
A61K38/00;A61K39/00;A61P35/00;C07K7/06;C07K7/08;C07K14/47;C12N1/19;C12N1/21;C12N15/12;(IPC1-7):C12N15/12;A61K39/395;C12N5/10;C07K14/82;C12P21/02;C07K16/32;A61K38/17;A61K31/708 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
